It's time to revisit a company I haven't covered in quite a while. As the title of this article gave away, that company is ResMed (RMD), a fast-growing healthcare company. Since then, shares have ...

ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from its major competitor. Despite a strong last quarter ...

ResMed (NYSE:RMD) is set to give its latest quarterly earnings report on Thursday, 2026-01-29. Here's what investors need to know before the announcement. Analysts estimate that ResMed will report an ...

ResMed Inc. RMD is gaining from strength in the Software-as-a-Service (SaaS) business and a robust product line. The company ended the first quarter of fiscal 2022 with better-than-expected results.